Mint-Alendronate · DIN 02394863 · 10 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2018-08-01 — choose a marketed DIN from the same-category list.Discontinued August 1, 2018 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2018-08-01 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2018-08-01 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Mint-Alendronate · DIN 02394863
Manufacturer: Mint Pharmaceuticals Inc.; listing date 2013-03-20
Health Canada: Cancelled post market since 2018-08-01 · brand MINT-ALENDRONATE · ATC M05BA04 ALENDRONIC ACID · form Tablet · route Oral · ingredients ALENDRONIC ACID (ALENDRONATE SODIUM) 10.0 MG · company Mint pharmaceuticals inc · schedule Prescription
Mint-Alendronate: Formulary list price $0.50 per unit (the source does not state the unit; exact figure $0.4987). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02394863)
Source record
DIN 02394863: Mint-Alendronate
Raw flags: chronicUseMed=Y, sec3=Y
Item: 920000232; group id 891; item number 2141; lccId None; manufacturer id MIN
Source form: Tab; strength: 10mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4987; ministry $0.4987
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02394863
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88002
Interchangeable products
Alendronate Sodium Tablets · DIN 02381486 · $0.4987
Apo-Alendronate · DIN 02248728 · $0.4987
Auro-Alendronate · DIN 02388545 · $0.4987
Fosamax · DIN 02201011 · not recorded
Ran-Alendronate · DIN 02384701 · $0.4987
Sandoz Alendronate · DIN 02288087 · $0.4987
Teva-Alendronate · DIN 02247373 · $0.4987
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since August 1, 2018 — choose a marketed DIN from the same-category list.